Podiatric adverse events and foot care in cancer patients and survivors: Awareness, education, and literature review

Mario E. Lacouture, David J. Kopsky, Raphael Lilker, Fiona Damstra, Mecheline H.M. Van Der Linden, Azael Freites-Martinez, Mischa P.M. Nagel*

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

Abstract

Cancer is one of the leading causes of mortality and morbidity worldwide. Recent improved therapies have resulted in more patients surviving cancer and living longer. Despite these advances, the majority of patients will develop adverse events from anticancer therapies. Foot alterations, including nail toxicities, hand-foot syndrome, edema, xerosis, hyperkeratosis, and neuropathy, are frequent among cancer patients. These untoward conditions may negatively impact quality of life, and in some cases may result in the interruption or discontinuation of cancer treatments. Appropriate prevention, diagnosis, and management of podiatric adverse events are essential to maintain foot function and health-related quality of life, both of which are critical for the care of cancer patients and survivors. This article shows results related to complaint and impact on quality of life of the Oncology Foot Care program and reviews publications specific to podiatric adverse events related to cancer treatments.

Original languageEnglish
Pages (from-to)508-516
Number of pages9
JournalJournal of the american podiatric medical association
Volume108
Issue number6
DOIs
Publication statusPublished - 1 Nov 2018

Cite this